Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

General

‘Tesla Extends Delivery Times For All Cars, But Not All Versions’ -Inside EVs

https://insideevs.com/news/538837/tesla-delivery-time-extended/amp/

byBill Haddad

October 6, 2021

1 minute read

https://insideevs.com/news/538837/tesla-delivery-time-extended/amp/

Whales Are Buying Dogecoin, The Meme Crypto Ranks Among The Most Actively Used Smart Contracts

By Bibhu Pattnaik

Today, 3:22 PM

According to the smart contract activity, the Dogecoin (CRYPTO: DOGE) is being accumulated by whales as investors buy the dip.

$DOGE

Pyxis Oncology In-Licenses Anti-Siglec-15 Monoclonal Antibody From Biosion

By Vandana Singh

Today, 3:22 PM

Pyxis Oncology Inc (NASDAQ: PYXS) has

PYXS

SpringWorks Therapeutics To Present Progress Across Company’s Targeted Oncology Portfolio At Virtual R&D Day

By Bill Haddad

Today, 3:22 PM

-- NDA filing for Nirogacestat in Desmoid Tumors, Which Will Be Reviewed Under the FDA's Real-Time Oncology Review (RTOR) Program, Expected in Second Half of 2022 -- -- New Phase 2 Study Announced to Evaluate

SWTX

Delcath Systems, Inc. Announces Phase 3 FOCUS Trial Results For Hepzato In Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis

By Benzinga Newsdesk

Today, 3:22 PM

On final analysis of the primary overall response (ORR) endpoint, HEPZATO further exceeded the predefined threshold for success with a median duration of response of 14 months While overall survival data continues to

DCTH

‘Tesla Extends Delivery Times For All Cars, But Not All Versions’ -Inside EVs

Related Posts

Whales Are Buying Dogecoin, The Meme Crypto Ranks Among The Most Actively Used Smart Contracts

Pyxis Oncology In-Licenses Anti-Siglec-15 Monoclonal Antibody From Biosion

SpringWorks Therapeutics To Present Progress Across Company’s Targeted Oncology Portfolio At Virtual R&D Day

Delcath Systems, Inc. Announces Phase 3 FOCUS Trial Results For Hepzato In Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis